Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer. Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Company Announcement Interim analysis of PROLONG study met primary endpoint Further analysis of safety and efficacy data underway Interim analysis to be shared with regulatory...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -13.386 | -5.14846153846 | 260 | 267.33 | 236.45 | 600 | 253.01632378 | CS |
4 | -25.422 | -9.3450866797 | 272.036 | 282.06 | 236.45 | 662 | 266.33899507 | CS |
12 | 5.524 | 2.29126052512 | 241.09 | 292.8 | 236.45 | 2226 | 270.87833734 | CS |
26 | -58.286 | -19.1164316169 | 304.9 | 310.56 | 236.45 | 1337 | 273.10573708 | CS |
52 | -109.9859 | -30.8429419077 | 356.5999 | 375 | 236.45 | 1176 | 284.28511396 | CS |
156 | -184.046 | -42.7358008638 | 430.66 | 479.99 | 236.45 | 993 | 331.02731781 | CS |
260 | 38.614 | 18.5644230769 | 208 | 500.92 | 159.45 | 1197 | 320.03868434 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.